SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Cadila receives two product approvals from USFDA

15 Sep 2017 Evaluate

Zydus Cadila has received the final approval from the United States Food & Drug Administration (USFDA) to market Modafinil tablets USP, 100 mg and 200 mg. Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnoea or shift work disorder. The sales of Modafinil tablets USP are estimated at $148.66 million, as per IMS Health.

The group also received the tentative approval for Solifenacin Succinate tablets in strengths of 5 mg and 10 mg. Solifenacin Succinate tablets are indicated for the treatment of overactive bladder associated with symptoms of urinary incontinence and urinary frequency. The sales of Solifenacin Succinate tablets are estimated at $1.04 billion, as per IMS Health.

Both the drugs will be manufactured at the group's formulations manufacturing facility at the Pharma SEZ, Ahmedabad. The group now has more than 150 approvals and has so far filed over 300 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Lifesciences Share Price

947.10 17.50 (1.88%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×